sFRP-2 activated the Wnt pathway and promoted renal cancer growth [111] whereas sFRP-3 expression induced the MMP-3 and ANGPT1 genes in renal cancer and thus contributed to the invasive capability of RCC [112]. Here, SFRP2 is linked to renal carcinoma.